CHIMERNA THERAPEUTICS, INC.
Chimerna Therapeutics
NEW YORK, United States · Founded 2020
- Headquarters
- NEW YORK, New York
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- chimerna.com
- Last Round
- Grant
- Rounds
- 1
About
Chimerna Therapeutics is a biotechnology company developing a circular RNA platform (Tornado technology) that overcomes the core limitations of RNA therapeutics — stability and abundance. By converting linear RNA into stable circular forms, Chimerna's platform enables therapeutic and research applications including aptamers, molecular sponges, protein expression, and treatments targeting neurodegeneration diseases.
Summary
CHIMERNA THERAPEUTICS, INC. is a Biotech company based in NEW YORK, United States, founded in 2020. Investors include NIH.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.